Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001589565 | SCV001815154 | uncertain significance | not provided | 2021-02-24 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function |
Labcorp Genetics |
RCV001589565 | SCV002162403 | likely benign | not provided | 2024-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004980606 | SCV005557934 | uncertain significance | Inborn genetic diseases | 2024-11-26 | criteria provided, single submitter | clinical testing | The c.2591C>A (p.S864Y) alteration is located in exon 35 (coding exon 35) of the COL11A2 gene. This alteration results from a C to A substitution at nucleotide position 2591, causing the serine (S) at amino acid position 864 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |